BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1322657)

  • 1. Replicative difference in early-passage feline brain cells among feline immunodeficiency virus isolates.
    Kawaguchi Y; Maeda K; Tohya Y; Furuya T; Miyazawa T; Horimoto T; Norimine J; Kai C; Mikami T
    Arch Virol; 1992; 125(1-4):347-54. PubMed ID: 1322657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A determinant of feline immunodeficiency virus involved in Crandell feline kidney cell tropism.
    Siebelink KH; Karlas JA; Rimmelzwaan GF; Osterhaus AD; Bosch ML
    Vet Immunol Immunopathol; 1995 May; 46(1-2):61-9. PubMed ID: 7542413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the cell tropism of feline immunodeficiency virus isolates of subtypes A, B and D classified on the basis of the env gene V3-V5 sequence.
    Hohdatsu T; Hirabayashi H; Motokawa K; Koyama H
    J Gen Virol; 1996 Jan; 77 ( Pt 1)():93-100. PubMed ID: 8558132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of biological properties of feline immunodeficiency virus isolates using recombinant chimeric viruses.
    Kohmoto M; Miyazawa T; Tomonaga K; Kawaguchi Y; Mori T; Tohya Y; Kai C; Mikami T
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1935-42. PubMed ID: 8046395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feline immunodeficiency virus decreases cell-cell communication and mitochondrial membrane potential.
    Danave IR; Tiffany-Castiglioni E; Zenger E; Barhoumi R; Burghardt RC; Collisson EW
    J Virol; 1994 Oct; 68(10):6745-50. PubMed ID: 8084006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
    Kawaguchi Y; Tomonaga K; Maeda K; Ono M; Miyazawa T; Kohmoto M; Tohya Y; Mikami T
    Virology; 1995 Apr; 208(2):492-9. PubMed ID: 7747422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity.
    Johnston JB; Power C
    J Virol; 2002 Apr; 76(8):3626-36. PubMed ID: 11907202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties.
    Pancino G; Castelot S; Sonigo P
    Virology; 1995 Feb; 206(2):796-806. PubMed ID: 7856093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A thermoresistant strain of feline immunodeficiency virus (FIV) with an altered cytopathic effect and a restricted cell tropism.
    Alix C; Koehren F; Martin JP; Kirn A; Braunwald J
    Arch Virol; 1998; 143(11):2093-107. PubMed ID: 9856096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro replication and cytopathogenicity of the feline immunodeficiency virus for feline T4 thymic lymphoma 3201 cells.
    Tochikura TS; Hayes KA; Cheney CM; Tanabe-Tochikura A; Rojko JL; Mathes LE; Olsen RG
    Virology; 1990 Nov; 179(1):492-7. PubMed ID: 1699355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication.
    Egberink HF; De Clercq E; Van Vliet AL; Balzarini J; Bridger GJ; Henson G; Horzinek MC; Schols D
    J Virol; 1999 Aug; 73(8):6346-52. PubMed ID: 10400726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cell tropism of feline immunodeficiency virus molecular clones in vivo.
    Dean GA; Himathongkham S; Sparger EE
    J Virol; 1999 Apr; 73(4):2596-603. PubMed ID: 10074104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system.
    Baldinotti F; Matteucci D; Mazzetti P; Giannelli C; Bandecchi P; Tozzini F; Bendinelli M
    J Virol; 1994 Jul; 68(7):4572-9. PubMed ID: 8207831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of Avemar treatment on feline immunodeficiency virus infected cell cultures.
    Tarcsai KR; Hidvégi M; Corolciuc O; Nagy K; Abbas AA; Ablashi DV; Kövesdi V; Ongrádi J
    Vet Med Sci; 2023 Jul; 9(4):1446-1455. PubMed ID: 37079719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus.
    Richardson J; Pancino G; Merat R; Leste-Lasserre T; Moraillon A; Schneider-Mergener J; Alizon M; Sonigo P; Heveker N
    J Virol; 1999 May; 73(5):3661-71. PubMed ID: 10196258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells.
    Verschoor EJ; Boven LA; Blaak H; van Vliet AL; Horzinek MC; de Ronde A
    J Virol; 1995 Aug; 69(8):4752-7. PubMed ID: 7609041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline immunodeficiency virus is shed in semen from experimentally and naturally infected cats.
    Jordan HL; Howard J; Barr MC; Kennedy-Stoskopf S; Levy JK; Tompkins WA
    AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1087-92. PubMed ID: 9718125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C.
    de Rozières S; Mathiason CK; Rolston MR; Chatterji U; Hoover EA; Elder JH
    J Virol; 2004 Sep; 78(17):8971-82. PubMed ID: 15308694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of feline immunodeficiency virus in feline and non-feline non-lymphoid cell lines by transfection of an infectious molecular clone.
    Miyazawa T; Kawaguchi Y; Kohmoto M; Sakuragi J; Adachi A; Fukasawa M; Mikami T
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1543-6. PubMed ID: 1318947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FIV infection of IL-2-dependent and -independent feline lymphocyte lines: host cells range distinctions and specific cytokine upregulation.
    Lerner DL; Grant CK; de Parseval A; Elder JH
    Vet Immunol Immunopathol; 1998 Oct; 65(2-4):277-97. PubMed ID: 9839880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.